Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 9
2010 7
2011 14
2012 5
2013 3
2014 2
2015 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.
Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, Huh WK, Sings HL, James MK, Haupt RM; FUTURE I and II Study Group. Joura EA, et al. Among authors: haupt rm. BMJ. 2012 Mar 27;344:e1401. doi: 10.1136/bmj.e1401. BMJ. 2012. PMID: 22454089 Free PMC article. Clinical Trial.
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.
Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D. Giuliano AR, et al. Among authors: haupt rm. N Engl J Med. 2011 Feb 3;364(5):401-11. doi: 10.1056/NEJMoa0909537. N Engl J Med. 2011. PMID: 21288094 Free PMC article. Clinical Trial.
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EI. Palefsky JM, et al. Among authors: haupt rm. N Engl J Med. 2011 Oct 27;365(17):1576-85. doi: 10.1056/NEJMoa1010971. N Engl J Med. 2011. PMID: 22029979 Free article. Clinical Trial.
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, Bautista O, Bryan J, Taddeo FJ, Esser MT, Vuocolo S, Haupt RM, Barr E, Saah A. Muñoz N, et al. Among authors: haupt rm. Lancet. 2009 Jun 6;373(9679):1949-57. doi: 10.1016/S0140-6736(09)60691-7. Epub 2009 Jun 1. Lancet. 2009. PMID: 19493565 Clinical Trial.
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
Castellsagué X, Muñoz N, Pitisuttithum P, Ferris D, Monsonego J, Ault K, Luna J, Myers E, Mallary S, Bautista OM, Bryan J, Vuocolo S, Haupt RM, Saah A. Castellsagué X, et al. Among authors: haupt rm. Br J Cancer. 2011 Jun 28;105(1):28-37. doi: 10.1038/bjc.2011.185. Epub 2011 May 31. Br J Cancer. 2011. PMID: 21629249 Free PMC article.
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015.
Vichnin M, Bonanni P, Klein NP, Garland SM, Block SL, Kjaer SK, Sings HL, Perez G, Haupt RM, Saah AJ, Lievano F, Velicer C, Drury R, Kuter BJ. Vichnin M, et al. Among authors: haupt rm. Pediatr Infect Dis J. 2015 Sep;34(9):983-91. doi: 10.1097/INF.0000000000000793. Pediatr Infect Dis J. 2015. PMID: 26107345 Review.
The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgery.
Gurtman A, Begier E, Mohamed N, Baber J, Sabharwal C, Haupt RM, Edwards H, Cooper D, Jansen KU, Anderson AS. Gurtman A, et al. Among authors: haupt rm. Hum Vaccin Immunother. 2019;15(2):358-370. doi: 10.1080/21645515.2018.1523093. Epub 2018 Sep 27. Hum Vaccin Immunother. 2019. PMID: 30215582 Free PMC article. Review.
Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.
Roberts C, Green T, Hess E, Matys K, Brown MJ, Haupt RM, Luxembourg A, Vuocolo S, Saah A, Antonello J. Roberts C, et al. Among authors: haupt rm. Hum Vaccin Immunother. 2014;10(8):2168-74. doi: 10.4161/hv.29205. Hum Vaccin Immunother. 2014. PMID: 25424920 Free PMC article. Review.
A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD.
Bonanni P, Cohet C, Kjaer SK, Latham NB, Lambert PH, Reisinger K, Haupt RM. Bonanni P, et al. Among authors: haupt rm. Vaccine. 2010 Jul 5;28(30):4719-30. doi: 10.1016/j.vaccine.2010.04.070. Epub 2010 May 6. Vaccine. 2010. PMID: 20451636 Review.
Age-based programs for vaccination against HPV.
Elbasha EH, Dasbach EJ, Insinga RP, Haupt RM, Barr E. Elbasha EH, et al. Among authors: haupt rm. Value Health. 2009 Jul-Aug;12(5):697-707. doi: 10.1111/j.1524-4733.2009.00512.x. Value Health. 2009. PMID: 19490561 Free article.
43 results
Jump to page
Feedback